50 c by christmas, page-36

First 36 Last

Share
Profile

Follow
matakus

147 Posts.

6

20/11/18

17:13

Post #: 36575881
Share

Originally posted by gregwallis: ↑

Would appear to be the case but what is the use of carving off the assets to a company and issuing shares that cannot be traded?
There is a huge potential for the previously unsellable assets in China. There is massive problems with copd and other problems caused by the high incidence of smoking that the government want to attack.
It is clear that the market thinks this company is on the nose. Shareholders are dumping their shares.
I hope you are right about the cancer treatment, it could be a game changer.
As I'm back miles behind the eight ball, almost as far as I was before, I will wait for the results next year, but be prepared for the southerly trajectory to continue.

Expand

The origins of Invion started with Cbio back in 2000-and was not listed on the ASX till 15/02/2010---10 years after inception.There was a secondary market for those who wanted to sell privately prior to that,cannot recall exactly how that operated.I think the main reason Nadalol did not find a partner was due to its generic status.Patent applications were for dosage and delivery methods-I have attached a link of a pod cast for those who have their doubts re nadalol with Dr Mitchell Glass who has bought 5 drugs to market (no mean feat). The Shareholders you mention who are dumping are probably mostly day and short term traders.Personally, I have no problems with what is happening at the moment.
http://webcasting.brrmedia.com/broadcast/133437

IVX Price at posting: 1.7¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply